Abstract
Several examples of highly modified antimicrobial peptides have been described. While many such peptides are non-ribosomally synthesized, ribosomally synthesised equivalents are being discovered with increased frequency. Of the latter group, the lantibiotics continue to attract most attention. In the present review, we discuss the implementation of in vivo and in vitro engineering systems to alter, and even enhance, the antimicrobial activity, antibacterial spectrum and physico-chemical properties, including heat stability, solubility, diffusion and protease resistance, of these compounds. Additionally, we discuss the potential applications of these lantibiotics for use as therapeutics.
Funding Information
  • Science Foundation Ireland (TIDA 14/TIDA/2286)
  • SFI Investigator awards to CH and RR (10/IN.1/B3027)
  • SFI-PI (11/PI/1137)
  • Alimentary Pharmabiotic Centre (SFI/12/RC/2273)

This publication has 86 references indexed in Scilit: